Dow Pharmaceutical Solutions

Our excipients and active pharmaceutical ingredients are designed to help solve customer challenges and address some of the most pressing health challenges and medical trends today.

ACTIVE PHARMACEUTICAL INGREDIENTS AND EXCIPIENTS BY DOW

Dow Pharma Solutions designs differentiated solutions that enable pharmaceutical delivery and help address some of the most pressing health challenges and medical trends today. A business of Dow Consumer Care, Dow Pharma Solutions offers a single interface to all Dow technologies and expertise focused on solutions serving the pharmaceutical markets. Thanks to decades of experience in the pharmaceutical industry, Dow has a proven track record working with customers around the globe to successfully develop approved functional excipients and active pharmaceutical ingredients (APIs) to help patients live healthier and more convenient lives.

Active Pharmaceutical Ingredients


Dow’s active pharmaceutical ingredients for hypercholesterolemia, hyperkalemia and intestinal health can help you provide safe and trusted treatment alternatives.


LEARN MORE

Multi-functional excipients


Our multi-functional excipients help address your delivery challenges in a multitude of dosage forms including tablets, capsules, liquids and topical applications.


LEARN MORE

NEWS, STORIES, AND EVENTS

  • news-press

    Dow Pharma and Food Solutions and Sirius Analytical Announce Strategic Agreement

    Dow Pharma and Food Solutions and Sirius Analytical Announce Strategic Agreement to Offer Biorelevant Equivalence Testing on FloVitro™ Platform Read More

  • news-press

    Dow Announces Global Launch and Commercial Availability of ETHOCEL™ High Productivity

    Dow Pharma & Food Solutions today announced the official global launch and commercial availability of ETHOCEL™ High Productivity (HP) a high productivity ethylcellulose polymer for multiparticulate and taste- masking applications, designed specifically for use with rotor coater systems. Read More

  • news-press

    Dow and Colorcon Extend and Broaden the Scope of the Controlled Release Alliance

    Colorcon Inc. and The Dow Chemical Company announced an agreement to broaden the existing Controlled Release Alliance between the two companies Read More

  • news-press

    Dow to Underscore its Expanded Pharma Offering and to Present Innovative Technologies for Topical Skin Management, Drug Delivery and Multiparticulate Systems at CPhI Worldwide 2016

    Dow Pharma & Food Solutions, a business unit of The Dow Chemical Company (NYSE: DOW) and Dow Corning, a wholly owned subsidiary of Dow, present latest innovations designed to address pharmaceutical industry needs at CPhI Worldwide, in Barcelona (Spain), October 4-6 2016. Read More

  • dow in the news

    Influence of AFFINISOL™ viscosity on HME processability and drug release

    Four grades of AFFINISOL™ HPMC HME were synthesized to specific target viscosities to first assess the ability to control the dissolution rate of a poorly soluble API using itraconazole (ITZ) as a model drug. These four grades were then used to prepare polymer blends to determine the influence of apparent viscosity on HME processing and ASD dissolution performance. Read More

  • dow in the news

    Performance of Amorphous Solid Dispersions of Ritonavir Prepared by Hot Melt Extrusion

    In this study amorphous solid dispersions of ritonavir (RTV) were prepared by hot melt extrusion using the polymeric carriers AFFINISOL™ HPMC HME and copovidone at 3 different drug loads (25%, 33% and 50% w/w RTV). The resulting solid dispersions were placed in accelerated stability testing conditions for 6 months. Read More

  • dow in the news

    Improving Productivity through Innovation

    Learn about ETHOCEL™ High Productivity - a new high productivity ethylcellulose polymer for multiparticulate and taste-masking applications that can help pharmaceutical companies to dry-coat barrier membranes in shorter coating times without the need for organic solvents. Read More

  • news-press

    Dow and Dow Corning Present Latest Technologies for Drug Delivery at AAPS 2016

    Dow and Dow Corning are presenting their latest innovative technologies and breakthroughs for the pharmaceutical industry here at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition. Read More

  • dow

    AAPS Annual Meeting and Exposition

    November 13-17, 2016
    Denver, Colorado
    Booth 1321
    Read More

  • dow

    CPhl Worldwide

    October 4-6, 2006
    Barcelona, Spain
    Booth 4J54
    Read More

  • dow

    Drug Delivery & Formulation Summit & Expo

    June 13-14, 2016
    San Diego, California
    Read More

  • dow

    Global Drug Delivery and Formulation Summit

    May 23-25, 2016
    Berlin, Germany
    Read More

  • dow

    PBP World Meeting

    April 4-7, 2016
    Glasgow, UK
    Booth 59
    Read More

Contact a representative

CONTACT US